Cargando…
Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
INTRODUCTION: Plasma lactate is a marker of non-oxidative glucose metabolism associated with progression to diabetes. We examined the effect of carbohydrate quality (glycemic index (GI)) and amount (%kcal) on plasma lactate. We hypothesized that low GI (≤45 (g)) versus high (≥65 (G)) and low %kcal f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462151/ https://www.ncbi.nlm.nih.gov/pubmed/32868311 http://dx.doi.org/10.1136/bmjdrc-2020-001457 |
_version_ | 1783576861359472640 |
---|---|
author | Hu, Jiun-Ruey Wu, Yingfei Sacks, Frank M Appel, Lawrence J Miller III, Edgar R Young, J Hunter Juraschek, Stephen P |
author_facet | Hu, Jiun-Ruey Wu, Yingfei Sacks, Frank M Appel, Lawrence J Miller III, Edgar R Young, J Hunter Juraschek, Stephen P |
author_sort | Hu, Jiun-Ruey |
collection | PubMed |
description | INTRODUCTION: Plasma lactate is a marker of non-oxidative glucose metabolism associated with progression to diabetes. We examined the effect of carbohydrate quality (glycemic index (GI)) and amount (%kcal) on plasma lactate. We hypothesized that low GI (≤45 (g)) versus high (≥65 (G)) and low %kcal from carbohydrate (40% kcal (c)) versus high (58% kcal (C)) each would reduce lactate levels. RESEARCH DESIGN AND METHODS: We measured lactate in OmniCarb, a randomized, cross-over trial of four diets in overweight/obese adults without diabetes or cardiovascular disease (N=163). The four diets were high carbohydrate+high GI (CG, reference), high carbohydrate+low GI (Cg), low carbohydrate+high GI (cG), and low carbohydrate+low GI (cg). Participants (N=163) consumed each of the four diets over a 5-week period, separated by 2-week washout periods. Plasma lactate levels were measured at baseline, during which the participants consumed their own diets, and after each 5-week period. RESULTS: Baseline plasma lactate was 1.2 mmol/L. In the setting of high carbohydrate amount, reducing GI lowered plasma lactate non-significantly by 0.08 mmol/L (Cg vs CG: 95% CI −0.16 to 0.00; p=0.06). In the setting of high GI, reducing carbohydrate amount lowered plasma lactate by 0.10 mmol/L (cG vs CG: 95% CI −0.19 to −0.02; p=0.02). The combined effect of reducing GI and carbohydrate proportion in the diet (cg vs CG) was similar (cg vs CG: −0.08; 95% CI −0.16 to 0.00; p=0.04). All four diets reduced plasma lactate compared with baseline. CONCLUSIONS: Compared with a diet with high GI and high carbohydrate amount, diets with low GI and/or low carbohydrate amount reduced plasma lactate. Whether this change in lactate leads to long-term change in glucose metabolism needs to be examined. TRIAL REGISTRATION NUMBER: NCT00608049. |
format | Online Article Text |
id | pubmed-7462151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74621512020-09-11 Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial Hu, Jiun-Ruey Wu, Yingfei Sacks, Frank M Appel, Lawrence J Miller III, Edgar R Young, J Hunter Juraschek, Stephen P BMJ Open Diabetes Res Care Clinical care/Education/Nutrition INTRODUCTION: Plasma lactate is a marker of non-oxidative glucose metabolism associated with progression to diabetes. We examined the effect of carbohydrate quality (glycemic index (GI)) and amount (%kcal) on plasma lactate. We hypothesized that low GI (≤45 (g)) versus high (≥65 (G)) and low %kcal from carbohydrate (40% kcal (c)) versus high (58% kcal (C)) each would reduce lactate levels. RESEARCH DESIGN AND METHODS: We measured lactate in OmniCarb, a randomized, cross-over trial of four diets in overweight/obese adults without diabetes or cardiovascular disease (N=163). The four diets were high carbohydrate+high GI (CG, reference), high carbohydrate+low GI (Cg), low carbohydrate+high GI (cG), and low carbohydrate+low GI (cg). Participants (N=163) consumed each of the four diets over a 5-week period, separated by 2-week washout periods. Plasma lactate levels were measured at baseline, during which the participants consumed their own diets, and after each 5-week period. RESULTS: Baseline plasma lactate was 1.2 mmol/L. In the setting of high carbohydrate amount, reducing GI lowered plasma lactate non-significantly by 0.08 mmol/L (Cg vs CG: 95% CI −0.16 to 0.00; p=0.06). In the setting of high GI, reducing carbohydrate amount lowered plasma lactate by 0.10 mmol/L (cG vs CG: 95% CI −0.19 to −0.02; p=0.02). The combined effect of reducing GI and carbohydrate proportion in the diet (cg vs CG) was similar (cg vs CG: −0.08; 95% CI −0.16 to 0.00; p=0.04). All four diets reduced plasma lactate compared with baseline. CONCLUSIONS: Compared with a diet with high GI and high carbohydrate amount, diets with low GI and/or low carbohydrate amount reduced plasma lactate. Whether this change in lactate leads to long-term change in glucose metabolism needs to be examined. TRIAL REGISTRATION NUMBER: NCT00608049. BMJ Publishing Group 2020-08-31 /pmc/articles/PMC7462151/ /pubmed/32868311 http://dx.doi.org/10.1136/bmjdrc-2020-001457 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Clinical care/Education/Nutrition Hu, Jiun-Ruey Wu, Yingfei Sacks, Frank M Appel, Lawrence J Miller III, Edgar R Young, J Hunter Juraschek, Stephen P Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial |
title | Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial |
title_full | Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial |
title_fullStr | Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial |
title_full_unstemmed | Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial |
title_short | Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial |
title_sort | effects of carbohydrate quality and amount on plasma lactate: results from the omnicarb trial |
topic | Clinical care/Education/Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462151/ https://www.ncbi.nlm.nih.gov/pubmed/32868311 http://dx.doi.org/10.1136/bmjdrc-2020-001457 |
work_keys_str_mv | AT hujiunruey effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial AT wuyingfei effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial AT sacksfrankm effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial AT appellawrencej effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial AT milleriiiedgarr effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial AT youngjhunter effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial AT juraschekstephenp effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial |